Cargando…
Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential
Di-phenyl-di-(2,4-difluobenzohydroxamato)tin(IV)(DPDFT), a new metal-based arylhydroxamate antitumor complex, showed high in vivo and in vitro antitumor activity with relative low toxicity, but no data was reported regarding its pharmacokinetics and dependent toxicity. In this paper, a rapid, sensit...
Autores principales: | Li, Yunlan, Gao, Zhuyan, Guo, Pu, Li, Qingshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287010/ https://www.ncbi.nlm.nih.gov/pubmed/22400014 http://dx.doi.org/10.1155/2012/210682 |
Ejemplares similares
-
Inhibition of Cytochrome P450 3A in Rat Liver by the Diorganotin (IV) Compound di-n-Butyl-di-(4-chlorobenzo-hydroxamato)tin (IV) and Its Probable Mechanism
por: Zhang, Yunxia, et al.
Publicado: (2012) -
Antitumor Activity of Di-n-Butyl-(2,6-Difluorobenzohydroxamato)Tin(IV) against Human Gastric Carcinoma SGC-7901 Cells via G2/M Cell Cycle Arrest and Cell Apoptosis
por: Yunlan, Li, et al.
Publicado: (2014) -
(O-Methyl dithiocarbonato-κS)triphenyltin(IV)
por: Javed, Fatima, et al.
Publicado: (2013) -
Dibromidodi-μ-hydroxido-di-μ(3)-oxido-octaphenyltetratin(IV)
por: Yap, Quai Ling, et al.
Publicado: (2009) -
Di-n-butylbis(N-ethyl-N-phenyldithiocarbamato-κS)tin(IV)
por: Kamaludin, Nurul Farahana, et al.
Publicado: (2011)